- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
No AEBAS Compliance, No Admissions for 2026-27: PCI Warns Pharmacy Colleges

New Delhi: The Pharmacy Council of India (PCI) has issued a stern warning to pharmacy institutions across the country, making strict implementation of the Aadhaar Enabled Biometric Attendance System (AEBAS) a decisive condition for approval and appeal consideration for the academic session 2026-2027, while warning that continued non-compliance may lead to rejection of applications and placement of institutions under the "Not to Make Admissions" category.
The circular, dated May 21, 2026, refers to appeals submitted by institutions against decisions communicated by the Council based on SIF, Inspection Reports, and appeals. PCI stated that despite multiple circulars and reminders regarding proper implementation of AEBAS and regular attendance marking by faculty members as per PCI norms, several institutions failed to ensure effective implementation and compliance.
According to the Council, many institutions completed only partial registration under the AEBAS system. In several cases, institutions registered on the portal but failed to install or map biometric devices. PCI also observed that faculty members were either not properly onboarded into the system or were not marking attendance regularly as mandated under PCI norms and guidelines.
PCI stated that such non-compliance reflects inadequate implementation despite repeated directions and sufficient opportunity provided by the Council. Institutions have now been advised to ensure complete implementation of AEBAS, including device integration, faculty onboarding, and regular attendance marking by all faculty members strictly as per PCI norms.
The Council further warned that failure to comply with AEBAS requirements will lead to non-consideration of appeal applications for the academic session 2026–27. PCI added that institutions will not be able to claim before any court of law that adequate opportunity was not provided or that appeals were not considered, as sufficient reminders and opportunities had already been given.
PCI also stated that continued non-compliance and failure to fulfil prescribed AEBAS requirements may result in rejection of applications or placing institutions under the “Not to Make Admissions” category for the academic session 2026–27.
To view the official notice, click the link below:
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

